SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Unitedhealth Group Inc – ‘10-K’ for 12/31/12 – ‘R22’

On:  Wednesday, 2/6/13, at 6:00pm ET   ·   As of:  2/7/13   ·   For:  12/31/12   ·   Accession #:  731766-13-5   ·   File #:  1-10864

Previous ‘10-K’:  ‘10-K’ on 2/9/12 for 12/31/11   ·   Next:  ‘10-K’ on 2/12/14 for 12/31/13   ·   Latest:  ‘10-K’ on 2/28/24 for 12/31/23   ·   5 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/07/13  Unitedhealth Group Inc            10-K       12/31/12  114:25M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.52M 
 2: EX-10.11    Material Contract                                   HTML     38K 
 3: EX-10.32    Material Contract                                   HTML     78K 
 4: EX-10.33    Material Contract                                   HTML     82K 
 5: EX-10.36    Material Contract                                   HTML    104K 
 6: EX-10.37    Material Contract                                   HTML     35K 
 8: EX-21.1     Subsidiaries List                                   HTML    229K 
 9: EX-23.1     Consent of Experts or Counsel                       HTML     34K 
10: EX-24.1     Power of Attorney                                   HTML     43K 
 7: EX-12.1     Statement re: Computation of Ratios                 HTML     47K 
11: EX-31.1     Certification -- §302 - SOA'02                      HTML     50K 
12: EX-32.1     Certification -- §906 - SOA'02                      HTML     38K 
78: R1          Document and Entity Information Document            HTML     62K 
63: R2          Condensed Consolidated Balance Sheets               HTML    164K 
74: R3          Condensed Consolidated Balance Sheet                HTML     69K 
                (Parenthetical) (Parentheticals)                                 
82: R4          Condensed Consolidated Statements of Operations     HTML    125K 
104: R5          Condensed Consolidated Statements of Comprehensive  HTML     92K  
                Income                                                           
65: R6          Condensed Consolidated Statements of Changes in     HTML    109K 
                Shareholders' Equity                                             
73: R7          Condensed Consolidated Statements of Cash Flows     HTML    173K 
57: R8          Description of Business                             HTML     38K 
47: R9          Basis of Presentation                               HTML    206K 
106: R10         Investments                                         HTML    270K  
84: R11         Fair Value                                          HTML    336K 
83: R12         Property, Equipment, and Capitalized Software       HTML     59K 
90: R13         Goodwill and Intangible Assets                      HTML    140K 
91: R14         Medical Costs and Medical Costs Payable             HTML     70K 
88: R15         Commercial Paper and Long-Term Debt                 HTML    216K 
92: R16         Income Taxes                                        HTML    158K 
75: R17         Shareholder's Equity                                HTML     65K 
79: R18         Share-Based Compensation                            HTML    119K 
86: R19         Commitments and Contingencies                       HTML     58K 
114: R20         Segment Financial Information                       HTML    307K  
100: R21         Quarterly Financial Data (Unaudited)                HTML     82K  
69: R22         Schedule I                                          HTML    195K 
85: R23         Basis of Presentation (Policy)                      HTML    185K 
71: R24         Fair Value Fair Value Policy (Policies)             HTML     50K 
38: R25         Income Taxes Income Tax (Policies)                  HTML     44K 
101: R26         Shareholder's Equity Shareholder's Equity           HTML     48K  
                (Policies)                                                       
110: R27         Share-Based Compensation Recognition (Policies)     HTML     52K  
52: R28         Segment Financial Information Segment Financial     HTML     43K 
                Information (Policies)                                           
51: R29         Basis of Presentation Basis of Presentation         HTML     75K 
                (Tables)                                                         
55: R30         Investments (Tables)                                HTML    268K 
56: R31         Fair Value (Tables)                                 HTML    324K 
58: R32         Property, Equipment, and Capitalized Software       HTML     58K 
                Property, Equipment, and Capitalized Software                    
                (Tables)                                                         
27: R33         Goodwill and Intangible Assets Goodwill and         HTML    141K 
                Intangible Assets(Tables)                                        
98: R34         Medical Costs and Medical Costs Payable Medical     HTML     72K 
                Cost Development (Tables)                                        
67: R35         Commercial Paper and Long-Term Debt (Tables)        HTML    210K 
70: R36         Income Taxes Income Tax (Tables)                    HTML    155K 
42: R37         Shareholder's Equity Shareholder's Equity (Tables)  HTML     43K 
113: R38         Share-Based Compensation (Tables)                   HTML    117K  
19: R39         Commitments and Contingencies Commitments and       HTML     46K 
                Contingencies (Tables)                                           
60: R40         Segment Financial Information (Tables)              HTML    292K 
103: R41         Quarterly Financial Data (Unaudited) Quarterly      HTML     80K  
                Financial Data (Unaudited) (Tables)                              
40: R42         Schedule I Schedule I (Tables)                      HTML    196K 
50: R43         Basis of Presentation Basis of Presentation Useful  HTML     37K 
                lives for property, equipment and capitalized                    
                software (Details)                                               
54: R44         Basis of Presentation Basis of Presentation         HTML     39K 
                Medicare Part D (Details)                                        
64: R45         Basis of Presentation Basis of Presentation         HTML     93K 
                Narrative (Details)                                              
26: R46         Investments (Narrative) (Details)                   HTML     37K 
46: R47         Investments (Short-Term and Long-Term Investments)  HTML     91K 
                (Details)                                                        
22: R48         Investments (Fair Value of Mortgage-Backed          HTML     54K 
                Securities by Credit Rating Origination) (Details)               
102: R49         Investments (Amortized Cost and Fair Value of       HTML     80K  
                Available-for-Sale Debt Securities by Contractual                
                Maturity) (Details)                                              
39: R50         Investments (Amortized Cost and Fair Value of       HTML     67K 
                Held-To-Maturity Debt Securities by Contractual                  
                Maturity) (Details)                                              
99: R51         Investments (Fair Value of Available-For-Sale       HTML     63K 
                Investments with Gross Unrealized Losses by                      
                Investment Type and Length of Time That Individual               
                Securities Have Been in a Continuous Unrealized                  
                Loss Position) (Details)                                         
43: R52         Investments (Net Realized Gains) (Details)          HTML     55K 
61: R53         Fair Value (Narrative) (Details)                    HTML     57K 
21: R54         Fair Value (Financial Assets and Liabilities,       HTML     76K 
                Excluding AARP, Measured at Fair Value on a                      
                Recurring Basis) (Details)                                       
24: R55         Fair Value (Financial Assets and Liabilities,       HTML     58K 
                Excluding AARP, Not Measured at Fair Value on a                  
                Recurring Basis) (Details)                                       
53: R56         Fair Value (Reconciliation of Assets Measured at    HTML     62K 
                Fair Value on a Recurring Basis Using Level 3                    
                Inputs) (Details)                                                
31: R57         Fair Value (Assets and Liabilities measured at      HTML     78K 
                fair value on a recurring basis) (Details)                       
107: R58         Fair Value Fair Value Inputs Assets Quantitative    HTML     43K  
                Information (Details)                                            
66: R59         Property, Equipment, and Capitalized Software       HTML     41K 
                Property, Equipment, and Capitalized Software                    
                Narrative (Details)                                              
89: R60         Property, Equipment, and Capitalized Software       HTML     63K 
                Property, Equipment, and Capitalized Software                    
                table (Details)                                                  
45: R61         Goodwill and Intangible Assets Goodwill and         HTML     90K 
                Intangible Assets Narrative (Details)                            
48: R62         Goodwill and Intangible Assets Goodwill (Changes    HTML     61K 
                in the Carrying Amount of Goodwill by Reporting                  
                Segment) (Details)                                               
96: R63         Goodwill and Intangible Assets Goodwill (Net        HTML     62K 
                Tangible Assets Acquired in Amil Acquisition)                    
                (Details)                                                        
93: R64         Goodwill and Intangible Assets Goodwill and Other   HTML     54K 
                Intangible Assets Gross carrying value,                          
                accumulated amortization and net carrying value of               
                intangible assets (Details)                                      
68: R65         Goodwill and Intangible Assets Goodwill and Other   HTML     44K 
                Intangible Assets Weighted-average useful lives                  
                assigned to finite-lived intangible assets                       
                acquired in business combinations (Details)                      
95: R66         Goodwill and Intangible Assets Goodwill and Other   HTML     43K 
                Intangible Assets Amortization Expense relating to               
                Intangible Assets (Details)                                      
44: R67         Medical Costs and Medical Costs Payable (Details)   HTML     35K 
72: R68         Medical Costs and Medical Costs Payable Medical     HTML     58K 
                Costs and Medical Costs Payable Rollforward                      
                (Details)                                                        
109: R69         Commercial Paper and Long-Term Debt (Narrative)     HTML     96K  
                (Details)                                                        
23: R70         Commercial Paper and Long-Term Debt (Commercial     HTML    107K 
                Paper and Long-Term Debt) (Details)                              
37: R71         Commercial Paper and Long-Term Debt Commercial      HTML     51K 
                Paper and Long-Term Debt Maturities of commercial                
                paper and long-term debt (Details)                               
62: R72         Income Taxes Income Tax Narrative (Details)         HTML     53K 
29: R73         Income Taxes Income Taxes Components of the         HTML     59K 
                provision for income taxes (Details)                             
112: R74         Income Taxes Income Taxes Reconciliation of the     HTML     81K  
                tax provision at the U.S. Federal Statutory Rate                 
                to the provision for income taxes (Details)                      
41: R75         Income Taxes Income taxes components of deferred    HTML    105K 
                tax assets and liabilities (Details)                             
32: R76         Income Taxes Income Taxes Reconciliation of the     HTML     53K 
                beginning and ending amount of unrecognized tax                  
                benefits (Details)                                               
36: R77         Shareholder's Equity Shareholder's Equity           HTML     80K 
                (Details)                                                        
25: R78         Share-Based Compensation (Narrative) (Details)      HTML     40K 
28: R79         Share-Based Compensation (Stock Option and SAR      HTML     88K 
                Activity) (Details)                                              
80: R80         Share-Based Compensation (Restricted Share          HTML     62K 
                Activity) (Details)                                              
34: R81         Share-Based Compensation Other Share-Based          HTML     69K 
                Compensation Data (Details)                                      
108: R82         Share-Based Compensation (Share-Based Compensation  HTML     52K  
                Principal Fair Value Assumptions) (Details)                      
59: R83         Commitments and Contingencies (Details)             HTML     41K 
87: R84         Commitments and Contingencies Future Lease          HTML     55K 
                Payments (Details)                                               
94: R85         Segment Financial Information (Details)             HTML    147K 
33: R86         Segment Financial Information Segment Financial     HTML     42K 
                Information (Narrative) (Details)                                
35: R87         Quarterly Financial Data (Unaudited) Quarterly      HTML     62K 
                Financial Data (Unaudited) (Details)                             
105: R88         Schedule I (Details)                                HTML     56K  
30: R89         Schedule I Schedule I Condensed Balance Sheet       HTML    117K 
                (Details)                                                        
81: R90         Schedule I Schedule I Condensed Balanch Sheet       HTML     59K 
                (Parentheticals) (Details)                                       
77: R91         Schedule I Schedule I Condensed Statment of         HTML     90K 
                Operations (Details)                                             
97: R92         Schedule I Schedule I Statement of Cash Flows       HTML    105K 
                (Details)                                                        
76: R93         Schedule I Parent Commercial Paper and Long-Term    HTML     48K 
                Debt Maturities of commercial paper and long-term                
                debt (Details)                                                   
111: XML         IDEA XML File -- Filing Summary                      XML    178K  
49: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   4.30M 
13: EX-101.INS  XBRL Instance -- unh-20121231                        XML   6.42M 
15: EX-101.CAL  XBRL Calculations -- unh-20121231_cal                XML    305K 
16: EX-101.DEF  XBRL Definitions -- unh-20121231_def                 XML   1.35M 
17: EX-101.LAB  XBRL Labels -- unh-20121231_lab                      XML   2.60M 
18: EX-101.PRE  XBRL Presentations -- unh-20121231_pre               XML   1.67M 
14: EX-101.SCH  XBRL Schema -- unh-20121231                          XSD    274K 
20: ZIP         XBRL Zipped Folder -- 0000731766-13-000005-xbrl      Zip    462K

‘R22’   —   Schedule I

This is an IDEA Financial Report.  [ Alternative Formats ]

 
v2.4.0.6
Schedule I
 12 Months Ended
Condensed Financial Statements, Captions [Line Items]  
Condensed Financial Information of Parent Company Only Disclosure [Text Block]
Schedule I
Condensed Financial Information of Registrant
(Parent Company Only)
UnitedHealth Group
Condensed Balance Sheets
 
(in millions, except per share data)
 
 
Assets
 
 
 
 
Current assets:
 
 
 
 
Cash and cash equivalents
 
$
1,025

 
$
1,506

Notes receivable from subsidiaries
 
2,889

 
—

Deferred income taxes, prepaid expenses and other current assets
 
225

 
179

Total current assets
 
4,139

 
1,685

Equity in net assets of subsidiaries
 
43,724

 
38,688

Other assets
 
106

 
77

Total assets
 
$
47,969

 
$
40,450

 
 
 
 
 
Liabilities and shareholders’ equity
 
 
 
 
Current liabilities:
 
 
 
 
Accounts payable and accrued liabilities
 
$
356

 
$
351

Note payable to subsidiary
 
175

 
145

Commercial paper and current maturities of long-term debt
 
2,541

 
982

Total current liabilities
 
3,072

 
1,478

Long-term debt, less current maturities
 
13,602

 
10,656

Deferred income taxes and other liabilities
 
117

 
24

Total liabilities
 
16,791

 
12,158

Commitments and contingencies (Note 4)
 
 
 
 
Shareholders’ equity:
 
 
 
 
Preferred stock, $0.001 par value -10 shares authorized; no shares issued or outstanding
 
—

 
—

Common stock, $0.01 par value - 3,000 shares authorized; 1,019 and 1,039 issued and outstanding
 
10

 
10

Additional paid-in capital
 
66

 
—

Retained earnings
 
30,664

 
27,821

Accumulated other comprehensive income
 
438

 
461

Total UnitedHealth Group shareholders’ equity
 
31,178

 
28,292

Total liabilities and shareholders’ equity
 
$
47,969

 
$
40,450








See Notes to the Condensed Financial Statements of Registrant
Schedule I
Condensed Financial Information of Registrant
(Parent Company Only)
UnitedHealth Group
Condensed Statements of Comprehensive Income
 
 
 
For the Years Ended December 31,
(in millions)
 
2012
 
2011
 
2010
Revenues:
 
 
 
 
 
 
Investment and other income
 
$
28

 
$
3

 
$
2

Total revenues
 
28

 
3

 
2

Operating costs:
 
 
 
 
 
 
Operating costs
 
(2
)
 
25

 
54

Interest expense
 
566

 
451

 
433

Total operating costs
 
564

 
476

 
487

Loss before income taxes
 
(536
)
 
(473
)
 
(485
)
Benefit for income taxes
 
192

 
167

 
180

Loss of parent company
 
(344
)
 
(306
)
 
(305
)
Equity in undistributed income of subsidiaries
 
5,870

 
5,448

 
4,939

Net earnings
 
5,526

 
5,142

 
4,634

Other comprehensive (loss) income
 
(23
)
 
209

 
(1
)
Comprehensive income
 
$
5,503

 
$
5,351

 
$
4,633













See Notes to the Condensed Financial Statements of Registrant
Schedule I
Condensed Financial Information of Registrant
(Parent Company Only)
UnitedHealth Group
Condensed Statements of Cash Flows
 
 
 
For the Years Ended December 31,
(in millions)
 
2012
 
2011
 
2010
Operating activities
 
 
 
 
 
 
Cash flows from operating activities
 
$
6,116

 
$
5,560

 
$
3,731

Investing activities
 
 
 
 
 
 
Cash paid for acquisitions
 
(3,737
)
 
(2,081
)
 
(2,470
)
Capital contributions to subsidiaries
 
(99
)
 
(171
)
 
(104
)
Cash flows used for investing activities
 
(3,836
)
 
(2,252
)
 
(2,574
)
Financing activities
 
 
 
 
 
 
Common stock repurchases
 
(3,084
)
 
(2,994
)
 
(2,517
)
Issuance of notes to subsidiaries
 
(4,149
)
 
—

 
—

Proceeds from common stock issuance
 
1,078

 
381

 
272

Cash dividends paid
 
(820
)
 
(651
)
 
(449
)
Proceeds from commercial paper, net
 
1,587

 
(933
)
 
930

Proceeds from issuance of long term debt
 
3,966

 
2,234

 
747

Repayments of long-term debt
 
(986
)
 
(955
)
 
(1,583
)
Interest rate swap termination
 
—

 
132

 
—

Proceeds of note from subsidiary
 
30

 
15

 
30

Other
 
(383
)
 
53

 
20

Cash flows used for financing activities
 
(2,761
)
 
(2,718
)
 
(2,550
)
(Decrease) increase in cash and cash equivalents
 
(481
)
 
590

 
(1,393
)
Cash and cash equivalents, beginning of period
 
1,506

 
916

 
2,309

Cash and cash equivalents, end of period
 
$
1,025

 
$
1,506

 
$
916

 
 
 
 
 
 
 
Supplemental cash flow disclosures
 
 
 
 
 
 
Cash paid for interest
 
$
547

 
$
418

 
$
459

Cash paid for income taxes
 
2,666

 
2,739

 
2,725










See Notes to the Condensed Financial Statements of Registrant
Schedule I
Condensed Financial Information of Registrant
(Parent Company Only)
UnitedHealth Group
Notes to Condensed Financial Statements
1.    Basis of Presentation
UnitedHealth Group’s parent company financial information has been derived from its consolidated financial statements and should be read in conjunction with the consolidated financial statements included in this Form 10-K. The accounting policies for the registrant are the same as those described in the Summary of Significant Accounting Policies in Note 2 of Notes to the Consolidated Financial Statements included in Item 8, “Financial Statements.”
2.    Subsidiary Transactions
Investment in Subsidiaries. UnitedHealth Group’s investment in subsidiaries is stated at cost plus equity in undistributed earnings of subsidiaries.
Notes Receivable from Subsidiaries. Notes issued to subsidiaries were used primarily to fund acquisitions. During 2012, the parent company completed a non-cash exchange of a $3.9 billion intercompany note to a subsidiary for a new term note of $2.6 billion and an equity interest of $1.3 billion.
Dividends. Cash dividends received from subsidiaries and included in Cash Flows from Operating Activities in the Condensed Statements of Cash Flows were $7.8 billion, $5.6 billion and $4.3 billion in 2012, 2011 and 2010, respectively.
3.    Commercial Paper and Long-Term Debt
Maturities of commercial paper and long-term debt for the years ending December 31 are as follows:
(in millions)
 
 
2013 (a)
 
$
2,541

2014
 
589

2015
 
1,067

2016
 
1,152

2017
 
1,281

Thereafter
 
9,513

(a)
Includes $9 million of debt subject to acceleration clauses.
Long-term debt obligations of the parent company do not include Brazilian real denominated debt of a subsidiary with a total par value of $588 million. Further information on commercial paper and long-term debt can be found in Note 8 of Notes to the Consolidated Financial Statements included in Item 8, “Financial Statements.”
4. Commitments and Contingencies
For a summary of commitments and contingencies, see Note 12 of Notes to the Consolidated Financial Statements included in Item 8, “Financial Statements.”

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed as of:2/7/13
Filed on:2/6/134
For Period end:12/31/1211-K,  3,  ARS
12/31/1110-K,  5
9/15/09
 List all Filings 

5 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/24/23  UnitedHealth Group Inc.           10-K       12/31/22  119:19M
 2/15/22  UnitedHealth Group Inc.           10-K       12/31/21  113:19M
 3/01/21  UnitedHealth Group Inc.           10-K       12/31/20  107:17M
 5/22/13  SEC                               UPLOAD10/06/17    1:34K  Unitedhealth Group Inc.
 3/21/13  SEC                               UPLOAD10/06/17    1:161K Unitedhealth Group Inc.
↑Top
Filing Submission 0000731766-13-000005   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Wed., May 15, 11:22:27.2am ET